Insider Transactions in Q4 2022 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.26%
|
$17,000
$17.06 P/Share
|
|
Nov 21
2022
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
1,720
-8.09%
|
$30,960
$18.19 P/Share
|
|
Nov 18
2022
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+18.66%
|
-
|
|
Nov 15
2022
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
3,403
-2.01%
|
$68,060
$20.01 P/Share
|
|
Nov 15
2022
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,020
+0.6%
|
$1,020
$1.68 P/Share
|
|
Nov 07
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.26%
|
$18,000
$18.0 P/Share
|
|
Oct 07
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.26%
|
$19,000
$19.51 P/Share
|
|
Oct 04
2022
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
6,000
-3.44%
|
$120,000
$20.29 P/Share
|